HPV-ASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX

Clinical trials for HPV-ASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX explained in plain language.

Never miss a new study

Get alerted when new HPV-ASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX trials appear

Sign up with your email to follow new studies for HPV-ASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could a Chemo-Immuno combo boost cancer fight before surgery?

Disease control Recruiting now

This phase 2 trial tests whether combining the chemotherapy 5-azacytidine with the immunotherapy nivolumab can make HPV-related head and neck cancer more responsive to treatment. About 50 people with resectable tumors will receive one or both drugs before surgery. The goal is to …

Matched conditions: HPV-ASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX

Phase: PHASE2 • Sponsor: Barbara Burtness • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

HPV-ASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX

Get alerted when new HPV-ASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX trials appear

Could a Chemo-Immuno combo boost cancer fight before surgery?